Prophylactic treatment of age-related macular degeneration report number 2: 810-Nanometer laser to eyes with drusen: Bilaterally eligible patients

Ophthalmic Surgery Lasers and Imaging

Volumn 40, Issue 6, 2009, Pages 530-538

  Friberg, Thomas R ^a,e   Brennen, Peter M ^a   Freeman, William R ^b   Musch, David C ^c   Arend, Laurence W ^d   Noguchi, Barbara ^d   Ferran, Janet ^d   Cochran, Denie ^b   Corbin, Patricia ^e   Garcia, Charles ^f   Gutierrez, Rebecca ^f   Olk, R Joseph ^g   Pollock, Karen ^g   Benner, Jeffrey D ^h   Schwartz, Joseph C ^h   Scott, Hannah ^h   Wong, Keye ⁱ   Miller, Rosa ⁱ   Awh, Carl C ^j   McHenry, Kristie ^j   Brown, Shonta ^j   Short, Mark ^j   Polk, Lisa ^j   Whitely, Julia ^j   Hines, Sarah ^j   Tanton, Amanda ^j   McDonald, Nichole ^j   Lazarus, Howard ^k   Bunch, Paige ^k   Lim, Jennifer I ^l   Chong, Lawrence ^l   Flaxel, Christina J ^l   Diddie, Ken ^l   Padillo, Margaret ^l   Walonker, Frances ^l   Rosen, Richard B ^m   Gentile, Ronald C ^m   Gedal, Amy ^m   Morse, Lawrence S ⁿ   Khodadadi, Navid ⁿ   Redline, Daniel ⁿ   Thomas, Mark ⁿ   Eckert, Marianna ⁿ   Hauser, David ⁿ   Morales, Ron ⁿ   Fox, Gregory M ^o   Moyer, Donna M ^o   Berger, Brian B ^p   Rathman, Jeni ^p   Quiroz Mercado, Hugo ^q   Mota, Sergio Hernandez Da ^q   Guerrero Naranjo, Jose Luis ^q   Saran, Bruce R ^r   Bourne, Avice ^r   Barnes, Charles H ^s   Frees, Melanie ^s   Kingsley, Ronald M ^t   Bradford, Reagan ^t   Burris, Russ ^t   Richmond, Rob ^t   Jobson, Jason ^t   Dwiggins, Connie ^t   Sinclair, Stephen H ^u   Roccio, Nancy L ^u   Tom, David ^v   Fiocco, Abby ^v   Ramsay, Robert C ^w   Johnson, Jill B ^w   Enloe, Julianne ^w   Phillips II, William B ^x   Rand, Lawrence I ^y   Wallace, Cheryl ^y   Whitney, John ^y   more..

^a UNIVERSITY OF PITTSBURGH MEDICAL CENTER   (United States)

^b UNIVERSITY OF CALIFORNIA SAN DIEGO   (United States)

^c UNIVERSITY OF MICHIGAN   (United States)

^d OCHSNER CLINIC FOUNDATION   (United States)

^e UNIVERSITY OF PITTSBURGH   (United States)

^f Hermann Eye Center   (United States)

^g Retina Center   (United States)

^h Retinal Consultants of Delmarva   (United States)

ⁱ Sarasota Retinal Institute   (United States)

^j Retina Vitreous Associates   (United States)

^k American Eye Institute   (United States)

^l UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^m NEW YORK EYE AND EAR INFIRMARY   (United States)

ⁿ UNIVERSITY OF CALIFORNIA   (United States)

^o The Retina Associates PA   (United States)

^p Austin Medical Plaza ^*  (United States)

^q Hospital to Prevent Blindness   (Mexico)

^r Chester County Eye Care Associates   (United States)

^s Wolfe Clinic   (United States)

^t UNIVERSITY OF OKLAHOMA HEALTH SCIENCES CENTER   (United States)

^u CROZER CHESTER MEDICAL CENTER   (United States)

^v New England Retina Associates   (United States)

^w VitreoRetinal Surgery   (United States)

^x Retina Group of Washington   (United States)

^y McGowan Eye Care Center   (United States)

more..

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIODE LASER; DRUSEN; EYE; FEMALE; HUMAN; LOW LEVEL LASER THERAPY; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROPHYLAXIS; RETINA FOVEA; RETINA MACULA AGE RELATED DEGENERATION; SUBRETINAL NEOVASCULARIZATION; THERAPY EFFECT; TREATMENT OUTCOME; VISUAL ACUITY;

AGED; FEMALE; FLUORESCEIN ANGIOGRAPHY; FOLLOW-UP STUDIES; FUNCTIONAL LATERALITY; FUNDUS OCULI; HUMANS; INCIDENCE; LASER COAGULATION; MACULAR DEGENERATION; MALE; MIDDLE AGED; PROPORTIONAL HAZARDS MODELS; RETINAL DRUSEN; RETROSPECTIVE STUDIES; TREATMENT OUTCOME; UNITED STATES; VISUAL ACUITY;

EID: 72249106970     PISSN: 15428877     EISSN: None     Source Type: Journal    
DOI: 10.3928/15428877-20091030-01     Document Type: Article

References (34)

1. Friedman DS, O'Colmain BJ, Munoz B, et al. Prevalence of age-related macular degeneration in the United States. Arch Ophthalmol. 2004;122:564-572. (Pubitemid 38456293)
2. Ferris FL 3rd, Fine SL, Hyman L. Age-related macular degeneration and blindness due to neovascular maculopathy. Arch Ophthalmol. 1984;102:1640-1642.
3. Gragoudas ES, Adamis AP, Cunningham ET Jr, et al. Pegaptanib for neovascular age-related macular degeneration. N Engl J Med. 2004;351:2805-2816. (Pubitemid 40051904)
4. Avery RL, Pieramici DJ, Rabena MD, et al. Intravitreal bevacizumab (Avastin) for neovascular age-related macular degeneration. Ophthalmology. 2006;113:363-372 e5.
5. Bressler SB, Maguire MG, Bressler NB, Fine SL. Relationship Relationship of drusen and abnormalities of the retinal pigment epithelium to the prognosis of neovascular macular degeneration. Arch Ophthalmol. 1990;108:1442-1447. (Pubitemid 20344701)
6. Holz FG, Wolfensberger TJ, Piguet B, et al. Bilateral macular drusen in age-related macular degeneration: prognosis and risk factors. Ophthalmology. 1994;101:1522-1528. (Pubitemid 24347050)
7. Smiddy WE, Fine SL. Prognosis of patients with bilateral macular drusen. Ophthalmology. 1984;91:271-277.
8. Age-Related Eye Disease Study Research Group. A randomized, placebo-controlled, clinical trial of high-dose supplementation with vitamins C and E and beta carotene for age-related cataract and vision loss: AREDS report no. 8. Arch Ophthalmol. 2001;119:1417-1436. (Pubitemid 32963246)
9. Age-Related Eye Disease Study Research Group. A randomized, placebo-controlled, clinical trial of high-dose supplementation with vitamins C and E and beta carotene for age-related cataract and vision loss: AREDS report no. 9. Arch Ophthalmol. 2001;119:1439-1452. (Pubitemid 32963247)
10. Figueroa MS, Regueras A, Bertrand J. Laser photocoagulation to treat macular soft drusen in age-related macular degeneration. Retina. 1994;14:391-396.
11. Frennesson IC, Nilsson SE. Laser photocoagulation of soft drusen in early age-related maculopathy (ARM): the one-year results of a prospective, randomised trial. Eur J Ophthalmol. 1996;6:307-314. (Pubitemid 26346060)
12. Guymer RH, Gross-Jendroska M, Owens SL, et al. Laser treatment in subjects with high-risk clinical features of age-related macular degeneration: posterior pole appearance and retinal function. Arch Ophthalmol. 1997;115:595-603. (Pubitemid 27204191)
13. Gass JD. Photocoagulation of macular lesions. Trans Am Acad Ophthalmol Otolaryngol. 1971;75:580-608.
14. Cleasby GW, Nakanishi AS, Norris JL. Prophylactic photocoagulation of the fellow eye in exudative senile maculopathy: a preliminary report. Mod Probl Ophthalmol. 1979;20:141-147.
15. Sarks SH, Arnold JJ, Sarks JP, et al. Prophylactic perifoveal laser treatment of soft drusen. Aust N Z J Ophthalmol. 1996;24:15-26. (Pubitemid 26200916)
16. Little HL, Showman JM, Brown BW. A pilot randomized controlled study on the effect of laser photocoagulation of confluent soft macular drusen. Ophthalmology. 1997;104:623-631.
17. Olk RJ, Friberg TR, Stickney KL, et al. Therapeutic benefits of infrared (810 nm) diode laser macular grid photocoagulation for nonexudative age-related macular degeneration: two-year results of a randomized pilot study. Ophthalmology. 1999;106:2082-2090.
18. Choroidal Neovascularization Prevention Trial Research Group. Laser treatment in eyes with large drusen: short-term effects seen in pilot randomized clinical trial. Ophthalmology. 1998;105:11-23.
19. Friberg TR, Musch DC, Lim JI, et al. Prophylactic treatment of age-related macular degeneration report number 1: 810-nanometer laser to eyes with drusen: unilaterally eligible patients. Ophthalmology. 2006;113:612-622.
20. Choroidal Neovascularization Prevention Trial Research Group. Laser treatment in fellow eyes with large drusen: updated findings from a pilot randomized clinical trial. Ophthalmology. 2003;110:971-978.
21. Owens SL, Bunce C, Brannon AJ, et al. Prophylactic laser treatment hastens choroidal neovascularization in unilateral age-related maculopathy: final results of the Drusen Laser Study. Am J Ophthalmol. 2006;141:276-281. (Pubitemid 43188026)
22. Lanchoney DM, Maguire MG, Fine SL. A model of the incidence and consequences of choroidal neovascularization secondary to age-related macular degeneration: comparative effects of current treatment and potential prophylaxis on visual outcomes in high-risk patients. Arch Ophthalmol. 1998;116:1045-1052.
23. Frennesson C, Nilsson SE. Prophylactic laser treatment in early age related maculopathy reduced the incidence of exudative complications. Br J Ophthalmol. 1998;82:1169-1174. (Pubitemid 28474874)
24. Marshall J. Interactions between sensory cells, glial cells and the retinal pigment epithelium and their response to photocoagulation. Dev Ophthalmol. 1981;2:308-317.
25. Duvall J, Tso MO. Cellular mechanisms of resolution of drusen after laser coagulation: an experimental study. Arch Ophthalmol. 1985;103:694-703. (Pubitemid 15052409)
26. Campochiaro PA, Hackett SF, Vinores SA, et al. Platelet-derived growth factor is an autocrine growth stimulator in retinal pigmented epithelial cells. J Cell Sci. 1994;107:2459-2469. (Pubitemid 24292494)
27. Yamamoto C, Ogata N, Yi X, et al. Immunolocalization of basic fibroblast growth factor during wound repair in rat retina after laser photocoagulation. Graefes Arch Clin Exp Ophthalmol. 1996;11:695-702. (Pubitemid 26387912)
28. Friberg TR, Karatza EC. The treatment of macular disease using a micropulsed and continuous wave 810-nm diode laser. Ophthalmology. 1997;104:2030-2038.
29. Moorman CM, Hamilton AM. Clinical applications of the MicroPulse diode laser. Eye. 1999;13:145-150. (Pubitemid 29210130)
30. Sivaprasad S, Sandhu R, Tandon A, et al. Subthreshold micropulse diode laser photocoagulation for clinically significant diabetic macular oedema: a three-year follow up. Clin Experiment Ophthalmol. 2007;35:640-644. (Pubitemid 47491221)
31. Mainster MA, Reichel E. Transpupillary thermotherapy for age-related macular degeneration: long-pulse photocoagulation, apoptosis, and heat shock proteins. Ophthalmic Surg Lasers. 2000;31:359-373. (Pubitemid 30727618)
32. Dorin G. Evolution of retinal laser therapy: minimum intensity photocoagulation (MIP): can the laser heal the retina without harming it? Semin Ophthalmol. 2004;19:62-68. (Pubitemid 39658411)
33. Hogan AC, Kilmartin DJ. Low power vs standard power transpupillary thermotherapy in patients with agerelated macular degeneration and subfoveal choroidal neovascularization ineligible for photodynamic therapy. Eye. 2006;20:649-654.
34. Lanzetta P, Dorin G, Pirracchio A, Bandello F. Theoretical bases of non-ophthalmoscopically visible endpoint photocoagulation. Semin Ophthalmol. 2001;16:8-11. (Pubitemid 34132526)